Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN395569 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Fibroblast Growth Factor 21 (FGF21) (AA 30-210) antibody
- Antibody type
- Monoclonal
- Description
- This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Mouse
- Epitope
- AA 30-210
- Isotype
- IgG
- Antibody clone number
- 2F11
- Vial size
- 100 μg
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles
Submitted references Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels.
Regulation of FGF21 expression and secretion by retinoic acid receptor-related orphan receptor alpha.
Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa.
FGF21 signalling pathway and metabolic traits - genetic association analysis.
Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.
Cuevas-Ramos D, Almeda-Valdes P, Gómez-Pérez FJ, Meza-Arana CE, Cruz-Bautista I, Arellano-Campos O, Navarrete-López M, Aguilar-Salinas CA
European journal of endocrinology 2010 Sep;163(3):469-77
European journal of endocrinology 2010 Sep;163(3):469-77
Regulation of FGF21 expression and secretion by retinoic acid receptor-related orphan receptor alpha.
Wang Y, Solt LA, Burris TP
The Journal of biological chemistry 2010 May 21;285(21):15668-73
The Journal of biological chemistry 2010 May 21;285(21):15668-73
Fibroblast growth factor-21 may mediate growth hormone resistance in anorexia nervosa.
Fazeli PK, Misra M, Goldstein M, Miller KK, Klibanski A
The Journal of clinical endocrinology and metabolism 2010 Jan;95(1):369-74
The Journal of clinical endocrinology and metabolism 2010 Jan;95(1):369-74
FGF21 signalling pathway and metabolic traits - genetic association analysis.
Kaess BM, Barnes TA, Stark K, Charchar FJ, Waterworth D, Song K, Wang WY, Vollenweider P, Waeber G, Mooser V, Zukowska-Szczechowska E, Samani NJ, Hengstenberg C, Tomaszewski M
European journal of human genetics : EJHG 2010 Dec;18(12):1344-8
European journal of human genetics : EJHG 2010 Dec;18(12):1344-8
Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.
Dushay J, Chui PC, Gopalakrishnan GS, Varela-Rey M, Crawley M, Fisher FM, Badman MK, Martinez-Chantar ML, Maratos-Flier E
Gastroenterology 2010 Aug;139(2):456-63
Gastroenterology 2010 Aug;139(2):456-63
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC
